White Paper
Orphan Drug Success: Engaging Key Stakeholders to Deliver Positive Outcomes
Rare diseases afflict as many as 30 million Americans, nearly 10% of the US population. Realizing the revenue potential of orphan drugs, midsize and large pharmaceutical companies...
White Paper
The New Healthcare: Marketing to a Segment of One
Technological advancements and shifts in the healthcare delivery model are pushing us toward a health economy in which pharma marketers increasingly focus their efforts on each...